NCT04308369

Brief Summary

Spa therapy is used in the treatment of various diseases and mainly osteoarthritis. Knee osteoarthritis is a very common rheumatic disease whose prevalence increases with longer life span and is a public health problem. The Forestier and al. study highlighted the actual benefit and confirmed the improvement of the quality of life and pain of the knee osteoarthritis patients from 6 months of spa treatment.\[1\] A significant decrease of 30% in the rate of Serum Hyaluronic Acid at 6 months after the end of the spa therapy was also highlighted in the Canteloup et al study.\[6\] This study aims to measure different osteoarticular biomarkers (hyaluronic acid, coll2-1 and CTX1) before, at the end of the spa therapy and 6 months after the spa therapy and correlate with the clinical evaluation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 16, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

September 15, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

2.8 years

First QC Date

March 5, 2020

Last Update Submit

June 30, 2023

Conditions

Keywords

Knee osteoarthritisspa therapyosteo-articular markers

Outcome Measures

Primary Outcomes (1)

  • Describe the change of serum level of Hyaluronic acid (a marker of synovial inflammation)

    Measure of serum level of Hyaluronic acid before the spa therapy (Day 0), at the end of the spa therapy (Week 3) and 6 months later (M6).

    6 months (timepoint: at Day 0, Week 3 and month 6)

Secondary Outcomes (6)

  • Marker of cartilage degradation: Coll2-1

    6 months (timepoint: at Day 0, Week 3 and month 6)

  • Marker of bone resorption: CTX1

    6 months (timepoint: at Day 0, Week 3 and month 6)

  • Index of symptomatic severity of knee osteoarthritis or WOMAC

    6 months (timepoint: at Day 0, Week 3 and month 6)

  • Pain evaluation Visual Analogue Scale

    6 months (timepoint: at Day 0, Week 3 and month 6)

  • SF 36 Quality of Life Questionnaire

    6 months (timepoint: at Day 0, Week 3 and month 6)

  • +1 more secondary outcomes

Study Arms (1)

Blood collection arm

OTHER

Blood collection will be performed before the spa therapy (Day 0), at the end of the spa therapy (Week 3) and 6 months later (M6).

Biological: Blood collection arm

Interventions

Blood collection will be performed before the spa therapy (Day 0), at the end of the spa therapy (Week 3) and 6 months later (M6). In this study, blood samples will be collected by a nurse of the service and centralized by the laboratory of Medical Biology of the General hospital of Dax.

Blood collection arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with knee osteoarthritis defined according to the recommendations of the American College of Rheumatology (ACR):
  • painful articulation and at least one of the following three criteria: age \> 50 years and/or articular crepitation and/or morning stiffness less than 30min
  • and radiographic sign of gonarthrosis with osteophyte (on X-rays of less than 3 years).
  • Patient can come to the final visit at 6 months and living within a perimeter of 30km around Dax.
  • Patient affiliated to a social security scheme.

You may not qualify if:

  • Osteoarthritis limited to patellofemoral joint.
  • A previous spa therapy of less than 6 months.
  • Spa therapies with double indication rheumatology and phlebology.
  • Patient with osteoporosis.
  • A known hepatocellular failure or known acute or end-stage renal failure.
  • Severe depressive syndrome, psychotic syndrome, immune deficiency, cardiopathy, evolutive neoplasia or infection.
  • Infiltration and/or viscosupplementation \< 6 months.
  • Change in anti-osteoarthritis treatment of less than 3 months.
  • Patient under tutorship or curatorship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

centre hospitalier Dax

Dax, 40100, France

Location

Related Publications (1)

  • Forestier R, Desfour H, Tessier JM, Francon A, Foote AM, Genty C, Rolland C, Roques CF, Bosson JL. Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial. Ann Rheum Dis. 2010 Apr;69(4):660-5. doi: 10.1136/ard.2009.113209. Epub 2009 Sep 3.

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Charles COWAN, MD

    CH de Dax

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: interventional study with minimal risk. Ony blood collection done during study to determinate biological marker level
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2020

First Posted

March 16, 2020

Study Start

September 15, 2020

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

July 3, 2023

Record last verified: 2023-06

Locations